Premium for New Drug Development to Be Continued on Trial Basis: CSIMC Expert Subcommittee

December 6, 2011
At a meeting on December 2, the Central Social Insurance Medical Council’s (CSIMC; Chuikyo ) Expert Subcommittee on NHI Drug Pricing Affairs basically agreed that the premium for the development of new drugs and elimination of off-label drug use, which...read more